Literature DB >> 24816958

Botulinum toxin versus botulinum toxin with low-dose glyceryltrinitrate for healing of chronic anal fissure: a prospective, randomised trial.

Muhammad Asim1, Neil Lowrie, Joanna Stewart, Simi Lolohea, Ralph Van Dalen.   

Abstract

BACKGROUND: Chronic anal fissure (CAF) is perpetuated by high sphincter pressures and secondary local ischemia. Pharmacological approaches include topical nitrates and botulinum toxin (BT), which both help to decrease the sphincter pressure. AIMS &
OBJECTIVES: The aims of the present study were to assess the efficacy and safety of BT injection and combined treatment with BT injection and lowered dose glyceryltrinitrate (GTN) cream for the treatment of CAF. We hypothesised that combined treatment would have a synergistic effect on healing.
METHODS: Forty-one consecutive patients with CAF were randomly assigned to receive one of the following treatments: Group A, injection of BT (20 U into internal anal sphincter) and Group B, BT injection (20 units) and subsequent thrice daily topical applications of half-dose 0.2% GTN cream for 6 weeks. Patients were followed up at 6 and 12 weeks and were assessed for healing of anal fissure, by means of visual inspection using fissure grades; for faecal incontinence, using Cleveland Clinic incontinence scores; and for fissure pain and headache using a numeric pain rating scale.
RESULTS: Fissure healing was similar in the two groups at both 6 (30% in BT and GTN and 33% in BT only) and 12 weeks (50% in BT and GTN vs 57% in BT-only group). Neither the change in pain score from 6 to 12 weeks, nor the overall level of pain was significantly different in the 2 groups. Moderate or severe headaches were suffered by 58% of patients using GTN.
CONCLUSION: Single-agent treatment by means of BT injection alone was well tolerated compared with combination treatment with BT injection and GTN cream, with no significant differences in healing of CAF observed in this small study.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24816958

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  7 in total

1.  High-dose versus low-dose botulinum toxin in anal fissure disease.

Authors:  P Ravindran; D L Chan; C Ciampa; R George; G Punch; S I White
Journal:  Tech Coloproctol       Date:  2017-10-28       Impact factor: 3.781

2.  Gastrointestinal Uses of Botulinum Toxin.

Authors:  Maria Cariati; Maria Michela Chiarello; Marco Cannistra'; Maria Antonietta Lerose; Giuseppe Brisinda
Journal:  Handb Exp Pharmacol       Date:  2021

Review 3.  A systematic review and meta-analysis of the treatment of anal fissure.

Authors:  R L Nelson; D Manuel; C Gumienny; B Spencer; K Patel; K Schmitt; D Castillo; A Bravo; A Yeboah-Sampong
Journal:  Tech Coloproctol       Date:  2017-08-09       Impact factor: 3.781

4.  Comparison of the effectiveness of two treatment modalities for chronic anal fissure: Botox versus sphincterotomy.

Authors:  Coskun Cakir; Ufuk Oguz Idiz; Ibrahim Aydin; Deniz Firat; Abdulhakim İbrahim Ulusoy; Pinar Yazici
Journal:  Turk J Surg       Date:  2020-09-28

5.  Is Intragastric Botulinum Toxin A Injection Effective in Obesity Treatment?

Authors:  Bulent Kaya; Nuriye Esen Bulut; Mahir Fersahoglu
Journal:  Surg Res Pract       Date:  2020-10-01

Review 6.  Treatment of gastrointestinal sphincters spasms with botulinum toxin A.

Authors:  Giuseppe Brisinda; Nicola Sivestrini; Giuseppe Bianco; Giorgio Maria
Journal:  Toxins (Basel)       Date:  2015-05-29       Impact factor: 4.546

Review 7.  Botulinum Toxin Injection for Treatment of Chronic Anal Fissure: Is There Any Dose-Dependent Efficiency? A Meta-Analysis.

Authors:  Adam Bobkiewicz; Wojciech Francuzik; Lukasz Krokowicz; Adam Studniarek; Witold Ledwosiński; Jacek Paszkowski; Michal Drews; Tomasz Banasiewicz
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.